In fact, it can be stated that the increase in the plasma level of apelin is a compensatory mechanism activated during insulin resistance because it has been found to increase the glucose uptake in the skeletal muscle and AT and repress lipolysis in healthy and insulin‐resistant rats (Bertrand et al., 2015). The gene discussed is APLN; the disease is Insulin resistance.